Viridian Therapeutics, Inc.
VRDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$270 | -$238 | -$130 | -$79 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $42 | $67 | $20 | $14 |
| Change in WC | $10 | -$9 | $16 | $2 |
| Other Non-Cash | -$15 | -$5 | $0 | $9 |
| Operating Cash Flow | -$232 | -$184 | -$94 | -$55 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$695 | -$408 | -$223 | -$188 |
| Inv. Sales/Matur. | $467 | $315 | $109 | $114 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$229 | -$94 | -$115 | -$74 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $15 | $5 | $0 |
| Stock Issued | $454 | $125 | $292 | $114 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | $86 | $25 | $11 |
| Financing Cash Flow | $458 | $226 | $322 | $125 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$53 | $113 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $103 | $156 | $42 | $46 |
| End Cash | $100 | $103 | $156 | $42 |
| Free Cash Flow | -$233 | -$185 | -$95 | -$55 |